OpenVSafe by OpenVAERS
Search V-safe

YT5-30668-98595

1 vaccination 1 coded response 6 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
021 / MA
Registered
2020-12-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Registered in v-safe
  2. 2020-12-29
    Dose 1 — Moderna
  3. 2020-12-29
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-01
    Survey response — 3 months, dose 1
    MedDRA: Hypersensitivity, Polymers allergy — Feeling: Good
    Free text: I had an immediate allergic reaction to polyethylene glycol, which I have not previously taken.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Moderna

Free text

Release 6 — 3 months, dose 1

2021-04-01

Symptoms: I had an immediate allergic reaction to polyethylene glycol, which I have not previously taken.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHypersensitivity ○ ✓ ○
SDPolymers allergy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release